Shree Ganesh Biotech (India) Ltd - 539470 - Compliance Certificate Pursuant To Regulation 7(3) Of The SEDI Listing Obligations And Disclosure Requirements) Reguiations, 2015 For The Period From April 1,2023 To March 31, 2024.
PFA24-04-2024
Shree Ganesh Biotech (India) Ltd - 539470 - Closure of Trading Window
Intimation of Closure of Trading Window for considering the Audited Financial Results of the company for the quarter and year ended as on 31.03.202429-03-2024
Shree Ganesh Biotech (India) Ltd - 539470 - Board Meeting Outcome for Un-Audited Financial Result Quarter Ended On 31St December 2023 Pursuant To Regulation 33 Of The SEBI (LODR) Regulations, 2015.
Pursuant to Second proviso to Regulation 30(6) and Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 we hereby inform you that the Board of Directors of the Company met in their meeting held on today i.e. Tuesday 13th February 2024. 1.) Considered and approved Un-audited financial results for the quarter ended as on 31st December 2023. The meeting commenced at 04:00 P.M. and concluded at 04:30.P.M. Kindly take the same on your record and oblige. Thanking You13-02-2024
Shree Ganesh Biotech (India) Ltd - 539470 - Revised Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the revised disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Shiv Corporation19-01-2024
Shree Ganesh Biotech (India) Ltd - 539470 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Shiv Corporation19-01-2024
Shree Ganesh Biotech (India) Ltd - 539470 - Board Meeting Intimation for Compliance Of Regulation 29 Of SEBI (LODR) Regulations, 2015 - Intimation Of Board Meeting.
Shree Ganesh Biotech (India) Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2024 ,inter alia, to consider and approve Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that a meeting of the Board of Directors of the Company will be held on Tuesday February 13 2024 inter alia, to approve and take on record the Un-Audited Financial Results of the Company for the quarter ended on 31st December 2023 also transact other business activities. Please take the above intimation in your records. Thanking You.18-01-2024